| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
Topotecan |
FIMM |
pan-cancer |
AAC |
-0.36 |
0.0002 |
| mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
0.0002 |
| mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
0.0002 |
| mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
0.0003 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0008 |
| mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0008 |